Multikinase inhibitors

TEVA 8199 TEVA 8199 Pill - maroon capsule-shape, 14mm

Pill with imprint TEVA 8199 TEVA 8199 is Maroon, Capsule-shape and has been identified as Sunitinib Malate 12.5 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Sunitinib is used in the treatment of Gastrointestinal Stromal Tumor; Renal Cell Carcinoma; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Sunitinib (Sunitinib [ soo-nit-in-ib ])-TEVA 8199 TEVA 8199-12.5 mg-Maroon-Capsule-shape

Sunitinib
Generic Name: sunitinib [ soo-nit-in-ib ]
Imprint: TEVA 8199 TEVA 8199
Strength: 12.5 mg
Color: Maroon
Size: 14.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Multikinase inhibitors VEGF/VEGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00093-8199
Inactive Ingredients: Croscarmellose sodium, Magnesium stearate, Mannitol, Povidone k30, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, Gelatin, Titanium dioxide, Ferrosoferric oxide, FD&C Blue No. 1 Aluminium Lake, FD&C Blue No. 2 Aluminium Lake, Shellac, Propylene glycol,
Latest News
Related Drugs